PHENTERMINE AND TOPIRAMATE
12 NDCs across 3 manufacturers|8 Generic,4 Brand
Total NDCs
12
8G / 4B
Manufacturers
3
competing in market
Price Spread
$2.95 – $6.37
Up to 54% savings
7d Activity
4↑4↓4 flat
of 12 total NDCs
Market Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
3 manufacturers producing PHENTERMINE AND TOPIRAMATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
QSYMIA 11.25 MG-69 MG CAPSULE | $6.3732 per EA | — |
QSYMIA 15 MG-92 MG CAPSULE | $6.3680 per EA | — |
QSYMIA 7.5 MG-46 MG CAPSULE | $5.9584 per EA | — |
QSYMIA 3.75 MG-23 MG CAPSULE | $5.7651 per EA | — |
PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE | $3.6356 per EA | -2.65% |
PHENTERMINE-TOPIRAMATE ER 15-92 MG CAPSULE | $3.6356 per EA | -2.65% |
PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE | $3.2753 per EA | +1.30% |
PHENTERMINE-TOPIRAMATE ER 7.5-46 MG CAPSULE | $3.2753 per EA | +1.30% |
PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE | $3.1276 per EA | -2.54% |
PHENTERMINE-TOPIRAMATE ER 11.25-69 MG CAPSULE | $3.1276 per EA | -2.54% |
PHENTERMINE-TOPIRAMATE ER 3.75-23 MG CAPSULE | $2.9549 per EA | +3.77% |
PHENTERMINE-TOPIRAMATE ER 3.75-23 MG CAPSULE | $2.9549 per EA | +3.77% |